2.75
7.09%
-0.21
Handel nachbörslich:
2.70
-0.05
-1.82%
Finanzdaten der Applied Dna Sciences Inc-Aktie (APDN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
14.29%
0.8912
|
0.7797 | 2.9173 | 4.4076 | 5.2628 |
Cost Of Revenue |
5.80%
0.6601
|
0.7007 | 1.648 | 2.6002 | 2.8851 |
Gross Profit |
192.54%
0.2311
|
0.079 | 1.2693 | 1.8074 | 2.3777 |
Operating Expenses
|
5.40%
4.0202
|
4.2498 | 4.1284 | 4.5115 | 3.5967 |
Benefits Costs and Expenses |
54.01%
2.0214
|
4.3954 | 6.0315 | 3.8564 | 9.107 |
Costs And Expenses |
54.01%
2.0214
|
4.3954 | 6.0315 | 3.8564 | 9.107 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
9.15%
-3.7891
|
-4.1708 | -2.8591 | -2.704 | -1.219 |
Net Interest Income/Expense |
19.17%
0.0333
|
0.0412 | 0.0268 | 0.00364 | 0.00369 |
Interest Income/Expense After Provision For Losses |
19.17%
0.0333
|
0.0412 | 0.0268 | 0.00364 | 0.00369 |
Income/Loss From Continuing Operations Before Tax |
68.74%
-1.1303
|
-3.6157 | -3.1142 | 0.5512 | -3.8442 |
Income/Loss From Continuing Operations After Tax |
68.74%
-1.1303
|
-3.6157 | -3.1142 | 0.5512 | -3.8442 |
Net Income/Loss
|
68.74%
-1.1303
|
-3.6157 | -3.1142 | 0.5512 | -3.8442 |
Preferred Stock Dividends And Other Adjustments |
0.0778
|
- | - | - | - |
Attributable To Noncontrolling Interest |
7.67%
-0.0252
|
-0.0234 | -0.0144 | -0.0372 | -0.000874 |
Basic Average Shares |
8,093%
13.67
|
0.1669 | 12.91 | 12.91 | 12.91 |
Diluted Average Shares |
8,093%
13.67
|
0.1669 | 12.91 | 12.91 | 12.91 |
Basic Earnings Per Share |
66.67%
-0.09
|
-0.27 | -0.24 | 0.05 | -0.30 |
Diluted Earnings Per Share |
66.67%
-0.09
|
-0.27 | -0.24 | 0.05 | -0.30 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
0.0778
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):